Qlucore adds another cancer diagnostics area

Qlucore, listed on Nasdaq First North, is delighted to announce a new collaboration in the field of precision diagnostics to develop solutions for improved clinical diagnostics of bladder cancer. Bladder cancer is the third classifier model co-operation launched by Qlucore in the area of solid tumours.

mdgroup Growth sees New VP, Product Delivery, Investing for the Future

mdgroup Growth sees New VP, Product Delivery, Investing for the Future Bracknell, UK: 19 May 2022 – mdgroup, the leading global provider of healthcare technologies and personalised clinical study services, has charged its new VP, Product Delivery, Mohamad (Mo) Merhi, with doubling the development team and recruiting the highest calibre of global talent in technological development and innovation.

BioMoti collaborates with global pharmaceutical company to develop ovarian cancer treatment and appoints Dr John Beadle as Chairman

BioMoti Ltd today announces an agreement with a global pharmaceutical company to collaborate on the development of its lead ovarian cancer candidate, BMT101, to clinical phase 2a proof-of-concept.

FDA grants 510k clearance of the CTL Amedica Navigation Instrument System

CTL Amedica Corporation has received official 510k clearance from the U.S. FDA to market the CTL Amedica Navigation Instrument System, registration number K213491. The system features manual surgical instruments adaptable for use with third-party navigation systems, which are designed to assist surgeons in precisely locating anatomical structures for preparation and placement of pedicle screws.

ZeOmega Unveils Novel Electronic Prior Authorization Solution

Through Partnerships with Change Healthcare and MCG, ZeOmega’s HealthUnity™ Smart Authorization Gateway Saves Time, Lowers Costs and Reduces Delays in Patient Care

BOC Sciences Officially Releases the Final Invitation to Renowned Pharma Conferences in May

As the two industry-renowned exhibitions—CPhI North America and TIDES USA 2022 draw near, BOC Sciences is making final efforts to let the news reach as many researchers as possible, especially those who are struggling to find the best mRNA services.

Carbohydrates of BOC Sciences Reveal Myriad Possibilities for Therapeutics

BOC Sciences updated several carbohydrates and derivatives in July 2020 and has kept a constant enlargement of product categories since then. Currently, it provides a full spectrum of carbohydrates that dramatically boost the research in Glycochemistry, Glycobiology, Glyco-analytics, and other Glycosciences.

LILLY RECEIVES MHRA MARKETING AUTHORISATION FOR ABEMACICLIB (VERZENIOS®▼) IN COMBINATION WITH ENDOCRINE THERAPY FOR ADJUVANT TREATMENT OF People with HR+, HER2- HIGH RISK EARLY BREAST CANCER

Four Well-Established Strategies Used in Hit Identification

A successful hit identification campaign relies on the use of a high-quality, diverse library of potential compounds to be screened, but also on capitalizing on other complementary techniques, such as structure-based virtual screening (SBVS) and fragment-based screening.

How to Synthesize Wax Esters? Three Synthetic Routes

Wax esters are esters formed by long-chain fatty acids and fatty alcohols. Owing to their biodegradability and good lubricity, wax esters can be used as base materials for advanced lubricants and advanced emollient oils for aviation, machinery, and chemical industries as well as for daily cosmetics and other fields. Wax esters can be divided into saturated and unsaturated types.

CD Formulation: How to Select Pharmaceutical Excipients

Pharmaceutical excipients refer to the substances used in the production and formulation of medicines. They perform multiple functions in pharmaceutical preparations and are likely to affect the quality, safety and effectiveness of drugs.

Alfa Chemistry Optimizes Its Microalgae Powder and Related Natural Extract Production Service

Deeply impressed by the huge potential of microalgae, Alfa Chemistry recently announced to optimize its production systems for microalgae powder and other related natural extracts. This service was first launched a few years ago and ever since then, it has gained over 75 patents in the fields of breeding, cultivation, processing and extract. With a team of biologists, engineers and technicians who are highly experienced with microalgae, the company decides to upgrade its production services by introducing more systematic procedures and more advanced equipment.

Alfa Chemistry Newly Releases the Offering of Forensic and Veterinary Standards

Through years of dedicated efforts, Alfa Chemistry has become one of the most popular suppliers of analytical reagents among customers across the globe. Chromatography standards are one of the best-selling categories among all products the company provides, and endeavors have never ceased to enrich such an offering. As a result, this month Alfa Chemistry announces that it has started to offer forensic and veterinary standards, another type of chromatography standards that could be used for forensic and veterinary research.

BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421, for Dry Eye Syndrome

BRIM Biotechnology, Inc. (“BRIM”), a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. (“ORA”), the world’s leading ophthalmic research organization for the late-stage clinical development of lead drug candidate, BRM421, for dry eye syndrome (DES). BRIM intends to initiate Phase 3 clinical studies with Ora’s support later this year.

Dotmatics supports Umicore Corporate R&D in processing of experimental data

N4 Pharma highlights potential of Nuvec® as gene therapy delivery platform

Gainwell Appoints Karen Shields as Chief Client Engagement Officer

VIDA Introduces New AI-Enabled Biomarker Services

New VIDA analysis packages & novel biomarkers empower trial sponsors to unlock breakthrough insights

BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca

BioIVT to Provide Rare Biosamples for the FNIH Biomarkers Consortium Neurodegenerative Disease Project

BioIVT is sourcing matched sets of cerebrospinal fluid, serum, and plasma from donors afflicted with ALS to further research of neurofilament in the blood as a biomarker for early stages of neurodegeneration.